Related Experiment Video

Updated: Aug 14, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Lipids and stroke: the opportunity of lipid-lowering treatment

José Vivancos-Mora1, Antonio C Gil-Núñez

  • 1Stroke Unit, Department of Neurology, Hospital Universitario de La Princesa, Madrid, Spain. jvivancosm@meditex.es

Cerebrovascular Diseases (Basel, Switzerland)
|December 6, 2005
PubMed

Insights

Statins effectively reduce ischemic stroke risk by 18-51% in high-risk patients. Emerging evidence suggests statins may benefit even those with normal cholesterol, highlighting their broader neuroprotective potential.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Dyslipidemia is a known risk factor for ischemic heart disease and peripheral artery disease.
  • The relationship between dyslipidemia and ischemic stroke (IS) is less clearly defined.
  • Statins are HMG-CoA reductase inhibitors used to manage dyslipidemia.

Purpose of the Study:

  • To evaluate the efficacy of statins in reducing the risk of ischemic stroke (IS).
  • To explore the potential for expanding statin indications beyond dyslipidemia management for IS prevention.
  • To investigate the non-lipid-lowering mechanisms of statins in the context of cerebral ischemia.

Main Methods:

  • Review of clinical evidence and studies, including the Heart Protection Study.
  • Analysis of statin efficacy in diverse patient groups including those with ischemic heart disease (IHD), high vascular disease risk, hypertension, acute coronary syndrome, and type 2 diabetes mellitus.
  • Consideration of statin use in patients with normal cholesterol or low-density lipoprotein levels.

Main Results:

  • Statins demonstrated a significant reduction in IS risk (18-51%) across various patient cohorts.
  • Current guidelines suggest statin use in most IS patients due to equivalent risk to IHD.
  • Non-lipid-lowering effects and studies like the Heart Protection Study support broader statin application.

Conclusions:

  • Statins are indicated for IS prevention in patients with dyslipidemia and other cardiovascular risk factors.
  • Evidence supports considering statins for IS prevention even in patients with normal lipid levels.
  • Further research is needed to clarify the neuroprotective role of statins in acute cerebral ischemia.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Structure of Lipids03:38

Structure of Lipids

Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic birds and...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...